Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80808 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Resolved | 2019-04-08 | 2020-07-13 | 80811 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-04-08 | 2019-07-19 | 80814 |
| MINT-PIOGLITAZONE | 15MG | TABLET | Resolved | 2019-07-04 | 2023-01-03 | 88502 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-24 | 2019-12-09 | 89913 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Actual shortage | 2019-08-22 | 2019-08-23 | 92272 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Actual shortage | 2019-08-22 | 2019-08-23 | 92275 |
| MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-10-09 | 2019-11-16 | 95919 |
| MINT-PIOGLITAZONE | 30MG | TABLET | Resolved | 2019-10-09 | 2023-01-03 | 95924 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95927 |
| MINT-SIMVASTATIN | 20MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95932 |
| MINT-SIMVASTATIN | 40MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95935 |
| MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95938 |
| MINT-PERINDOPRIL | 8MG | TABLET | Resolved | 2019-10-09 | 2019-10-22 | 95941 |
| MINT-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2019-10-09 | 2019-12-10 | 95944 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-09 | 2019-11-29 | 95947 |
| MINT-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100582 |
| MINT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100585 |
| MINT-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2020-03-09 | 2020-03-10 | 108289 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108295 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |